Correspondence re: Ghosh A and Heston WDW. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 91:528-539, 2004

Journal of Cellular Biochemistry

Volumn 93, Issue 4, 2004, Pages 641-643

  Cardillo, Maria Rosaria ^a   Gentile, V ^a   Di Silverio, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC MEMBRANE ANTIGEN; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; MEMBRANE ANTIGEN;

BLOOD; CLINICAL TRIAL; GLEASON SCORE; HUMAN; LETTER; MEDICAL LITERATURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; CELL LINE; GENE EXPRESSION; MALE; MULTIMODALITY CANCER THERAPY; NOTE; PROSTATE TUMOR; TUMOR EMBOLISM;

ANTIGENS, SURFACE; CELL LINE; COMBINED MODALITY THERAPY; GENE EXPRESSION; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; MALE; NEOPLASM CIRCULATING CELLS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 21744441663     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20244     Document Type: Letter

References (9)

1. Gala JL, Heusterpreute M, Loric S, Hanon F, Tombal B, Cangh PV, De Nayer P, Philippe M. 1998. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: Implications for the detection of hematogenous prostate cells and standardization. Clin Chem 44(3):472-481.
2. Ghosh A, Heston WDW. 2004. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 91:528-539.
3. Grasso Y, Gupta MK, Levin HS, Zippe CD, Klein EA. 1998. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: Correlation with pathological stage. Cancer Res 58:1456-1459.
4. Grauer LS, Lawler KD, Marignac JL, Kumar A, Goel AS, Wolfert RL. 1998. Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM protein in the LNCaP prostatic carcinoma cell line. Cancer Res 58:4787-4789.
5. Hara N, Kasahara T, Kawasaki T, Bilim V, Obara K, Takahaski K, Tomita Y. 2002. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: Value for the staging of prostate cancer. Clin Cancer Res 8:1794-1799.
6. Israeli RS, Powel CT, Fair WR, Heston WD. 1993. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 53(2): 227-230.
7. Lanes L, Ferruelo A, Pàez A, Gòmez JM, Moreno A, Berenguer A. 2002. The clinical utility of the prostate specific membrane antigen reverse-transcription/polymerase chain reaction to detect circulating prostate cells: An analysis in healthy men and women. Br J Int 89:882-885.
8. Martìnez-Pineiro L, Rios E, Martìnez-Gomariz M, Pastor T, de Cabo M, Picazo ML, Palacios J, Perona R. 2003. Molecular staging of prostatic cancer with RT-PCR assay for prostate-specific antigen in peripheral blood and lymph nodes: Comparison with standard histological staging and immunohistochemical assessment of occult regional lymph node metastases. Eur Urol 43:342-350.
9. Nakajima-Jijima S, Hamada H, Reddy P, Kakunaga T. 1985. Molecular structure of human cytoplasmic beta-actin gene: Interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 82(18):6133-6137.